TOC
The LazarusEffect
Cover Story
The LazarusEffect
Joanna Breitstein
Senior Editor
Antiretroviral drugs can bring patients back to life. But how do pharma's products get to patients at the heart of the world's biggest health disaster?
Features
Medicare
D-Day
Kevin Barnett
Campbell Alliance
The Medicare Prescription Drug Benefit doesn't begin until next year. But for pharma, a key deadline is right around the corner.
Marketing
The Sampling Subsidy
Nancy Lurker and Bob Caprara
ImpactRx
Sampling is an enormous part of pharmaceutical marketing. But no one has been sure what happens to samples—until now.
Annual Survey
The Rise and Fall of Pharma Reputations
Doretta W. Gasoreks and Jeffrey T. Resnick
Rating Research LLC
In a memorably bad year for pharma, a few companies still managed to shine.
Biopartnerships
Bridging the Gap
Lynda C. McDermott and Esther Fleischhacker
EquiPro International
It's not the deal that scuttles most strategic alliances. It's the culture. The key to success: Know your partner (and yourself).
News & Analysis
Leading Indicators
News
Pharma's tsunami aid
- The US government targets medical error
- USP unveils its Medicare formulary
- Registering clinical trials
- A newvaccine for rotavirus
- Is it finally time fortort reform?
Data
Do people still trust drugs?
- Top patent producers
Thought Leaders
Fran DeGrazio of West Pharmaceutical Services on packaging for biologics.
Washington Report
Safety is dominating the debate over drug regulation. And that's not all good.
Jill Wechsler
Global Report
British royalty: Cambridge Antibody Technologies wins its case against Abbott.
Sarah Houlton
Leadership
A successful leader has to be a full-time teacher.
Sander A. Flaum
Flaum Partners
Strategy & Tactics
Direct to Consumer
Direct mail is once again winning favor in the pharma marketing mix—just be sure to customize it.
Jay Bolling
Roska Direct
Marketing to Professionals
Do readers care who sponsors studies published in medical journals? Editors give their two cents.
Alternative Media
Blogger Matthew Holt cuts through the hype of disease management.
Medical Education
There are no great, cheap, and easy metrics out there to measure CME. But here's how to make what's available work for you.
Stephen Smith
MedsiteCME
Public Relations
The industry's operating paradigm is changing. And PR needs to change with it.
Wayne Pines
APCO Worldwide
Insights
From the Editor
AIDS in Africa: Don't think of it as a market. Think of it as a critique of the industry.
Patrick Clinton
Editor-in-Chief
Back Page
FDA is great at approving new drugs. But it needs to be great at some other jobs, too.
Jonathan Seltzer, MD
Applied Clinical Intelligence
Resources
People Update
Contacts
Calendar of Events
Advertisers Index
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
